New drug combo aims to halt aggressive prostate cancer
NCT ID NCT05826509
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 25 times
Summary
This study tests whether adding the drug darolutamide to surgery can delay the return or spread of high-risk prostate cancer. About 240 men will either have surgery alone or surgery plus darolutamide taken before and after the operation. The goal is to see if the combination keeps the cancer from becoming incurable longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Bordeaux
Bordeaux, France
-
CHU Grenoble
Grenoble, France
-
CHU Lyon - Hôpital Edouard Herriot
Lyon, France
-
CHU Lyon - Sud
Pierre-Bénite, France
-
CHU Rennes
Rennes, France
-
CHU Toulouse
Toulouse, France
-
Chu Angers
Angers, France
-
Chu Henri Mondor
Créteil, France
-
Chu Tours - Hopital Bretonneau
Tours, France
-
Clinique La Croix Du Sud
Quint-Fonsegrives, France
-
Hopital Claude Huriez
Lille, France
-
Hopital Europeen Georges-Pompidou
Paris, France
-
Hopital Foch
Suresnes, France
-
Hopital Paris Saint-Joseph
Paris, 75014, France
-
Hopital Pitie Salpetriere
Paris, France
-
Institut Bergonié
Bordeaux, France
-
Institut Mutualiste Montsouris
Paris, France
-
Institut Paoli-Calmettes
Marseille, France
-
Institut Universitaire Du Cancer Toulouse - Oncopole
Toulouse, France
Conditions
Explore the condition pages connected to this study.